Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology

Author： Marchese A.   George S.R.   Kolakowski L.F.   Lynch K.R.   O'Dowd B.F.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.20, Iss.9, 1999-09, pp. : 370-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands

By De Amici M.   Conti P.   Fasoli E.   Barocelli E.   Ballabeni V.   Bertoni S.   Impicciatore M.   Roth B.L.   Ernsberger P.   De Micheli C.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 739-748

Elsevier

Access to resources Recommend Favorite

TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling

By  

Current Neuropharmacology, Vol. 16, Iss. 2, 2018-01 ,pp. : 137-150

Bentham Science Publishers

Access to resources Recommend Favorite

Nonpeptide Ligands That Target Peptide-Activated GPCRs In Inflammation

By  

Current Medicinal Chemistry, Vol. 12, Iss. 25, 2005-12 ,pp. : 3027-3042

Bentham Science Publishers

Access to resources Recommend Favorite

Expanding boundaries of endocrinology

By Lumb Alistair   Wass John  

Clinical Medicine, Vol. 10, Iss. 3, 2010-06 ,pp. : 238-241

Royal College Of Physicians

Access to resources Recommend Favorite

Endogenous ligands and inverse agonism

By Baxter G.S.   Tilford N.S.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 8, 1995-08 ,pp. : 258-259

Elsevier

Access to resources Recommend Favorite